BC
Insider selling
Bernadette Connaughton sold $103K of Halozyme Therapeutics, Inc. (HALO) stock
Bernadette Connaughton, Dir of Halozyme Therapeutics, Inc. (HALO), sold 1,625 shares of HALO stock worth $103K, per an SEC Form 4 filed May 5, 2026.
It was an open-market sale.
The trade happened on May 1, 2026, 4 days before it was made public.
HALO has moved +74.2% since the trade date, from $63.96 to $111.45 (Sep 21, 2026 close).
- Traded
- May 1, 2026
- Disclosed
- May 5, 2026
- Filing delay
- 4 days
- Price since
- +74.2%
- Role
- Dir
- Source
- SEC Form 4
More HALO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.